Submission Details
Molecule(s):
Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1
Design Rationale:
The molecule is clemizole (Not newly designed one), I expect it to act as an inhibitor of RNA binding protein from SARS-CoV-2 . In preliminary docking studies it has shown good binding to fragment x0072 of the protease. PDB is attached for refrence.